Quantitative RT-PCR analysis of MMR genes on EUS-guided FNA samples from focal pancreatic lesions

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 916-920

  Gheonea, Dan Ionuţ ^a,b   Ciurea, Marius Eugen ^a   Sǎftoiu, Adrian ^a   Ioana, Mihai ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Mismatch excision repair; Pancreatic cancer

Indexed keywords

COMPLEMENTARY DNA; DNA; RNA;

ARTICLE; ASPIRATION BIOPSY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DNA REPAIR; ENDOSCOPIC ECHOGRAPHY; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMAN; MISMATCH REPAIR; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASOUND;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALGORITHMS; BIOPSY, FINE-NEEDLE; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; ENDOSONOGRAPHY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; ROMANIA; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84860537886     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11463     Document Type: Article

References (23)

1. Kesavan Y, Giovannucci E, Fuchs CS, et al.: A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol 2010; 171:233-241.
2. Jemal A, Murray T, Samuels A, et al.: Cancer statistics 2003. CA Cancer J Clin 2003; 53:5-26.
3. Garcea G, Neal CP, Pattenden CJ, et al.: Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005; 41:2213-36. (Pubitemid 41415597)
4. Moore PS, Orlandini S, Zamboni G, et al.: Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer 2001; 84:253-262. (Pubitemid 32113454)
5. Rozenblum E, Schutte M, Goggins M, et al.: Tumour-suppressive pathways in pancreatic carcinoma. Cancer Res 1997; 57:1731-1734.
6. Haring SJ, Humphreys TD, Wold MS: A naturally occurring human RPA subunit homolog does not support DNA replication or cell-cycle progression. Nucleic Acids Res 2010; 38:846-58.
7. Harfe BD, Jinks-Robertson S: DNA mismatch repair and genetic instability. Annu Rev Genet 2000; 34:359-399. (Pubitemid 32065926)
8. Gargiulo S, Torrini M, Ollila S, Nasti, et al.: Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Fam Cancer 2009; 8:547-53.
9. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 2003; 348:919-932. (Pubitemid 36298000)
10. Vasen HF, Watson P, Mecklin JP, et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-1456. (Pubitemid 29258894)
11. Van Eijk R, Licht J, Schrumpf M, et al.: Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR. PLoS One 2011; 6:e17791.
12. Wallace MB, Block M, Hoffman BJ: Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med 2003; 167:1670-1675. (Pubitemid 36760682)
13. Ashida R, Nakata B, Shigekawa M, et al.: Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. J Exp Clin Cancer Res 2009; 28:83.
14. Habbe N, Langer P, Sina-Frey M: Familial pancreatic cancer syndromes. Endocrinol Metab Clin North Am 2006; 35:417-430.
15. Li D, Suzuki H, Liu B, et al.: DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 2009; 15:740-746.
16. Laurell H, Bouisson M, Berthelemy P, et al.: Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006; 12:3344-3451.
17. Handra-Luca A, Couvelard A, Degott C, et al.: Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Virchows Arch 2004; 444:235-238. (Pubitemid 38446435)
18. Dong X, Li Y, Hess KR, Abbruzzese JL, et al.: DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. Oncologist 2011; 16:61-70.
19. Shahi A, Lee JH, Kang Y, et al.: Mismatch-repair protein MSH6 is associated with Ku70 and regulates DNA double-strand break repair. Nucleic Acids Res 2011; 39:2130-2143.
20. Barrera-Oro J, Liu TY, Gorden E: Role of the mismatch repair gene, Msh6, in suppressing genome instability and radiation-induced mutations. Mutat Res 2008; 642:74-79.
21. Kahl S, Malfertheiner P: Role of endoscopic ultrasound in the diagnosis of patients with solid pancreatic masses. Dig Dis 2004; 22: 26-31. (Pubitemid 39070144)
22. Laurell H, Bouisson M, Berthelemy P, et al.: Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006; 7:12(21):3344-51.
23. Pusztai L, Ayers M, Stec J, et al.: Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. Clin Cancer Res 2003; 9:2406-2415. (Pubitemid 36842079)